Full Text View
Tabular View
No Study Results Posted
Related Studies
A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
This study is ongoing, but not recruiting participants.
Study NCT01093157   Information provided by University Health Network, Toronto

First Received on March 24, 2010.   Last Updated on January 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glomerulonephritis
Additional conditions recognized in this trial
Glomerulonephritis, Membranous
Kidney Diseases
More general conditions related to this trial
Autoimmune Diseases
Immune System Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Adrenocorticotrophic hormone ACTH
Additional drug interventions recognized in this trial
Adrenocorticotropic Hormone
Beta-Endorphin
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University Health Network, Toronto
Questcor Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services